Scientific Sessions 2024  /  Featured Science: Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations  /  Discussant: VALOR-HCM
Logo

American Heart Association

  183
  0

Final ID:

Discussant: VALOR-HCM

  • Deswal, Anita  ( Univ. of Texas MD Anderson Cancer Center , Bellaire , Texas , United States )
  • Ho, Jennifer  ( Harvard Medical School , Newton , Massachusetts , United States )
  • Ho, Carolyn  ( Carolyn Ho , Brookline , Massachusetts , United States )
  • Day, Sharlene  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Anita Deswal: DO have relevant financial relationships ; Consultant:Bayer (Any division):Active (exists now) | Jennifer Ho: DO have relevant financial relationships ; Individual Stocks/Stock Options:Pfizer:Active (exists now) | Carolyn Ho: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers Squib:Active (exists now) ; Consultant:viz.ai:Active (exists now) ; Consultant:Lexicon:Active (exists now) ; Consultant:Tenaya:Active (exists now) ; Research Funding (PI or named investigator):Tenaya:Active (exists now) ; Consultant:Biomarin:Active (exists now) ; Research Funding (PI or named investigator):Biomarin:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Cytokinetics:Active (exists now) ; Consultant:Bristol Myers Squib:Active (exists now) | Sharlene Day: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations

Monday, 11/18/2024 , 09:45AM - 11:00AM

Featured Science

More abstracts on this topic:
Acoramidis Reduces All-Cause Mortality (ACM) and Cardiovascular-Related Hospitalization (CVH): Initial Outcomes From the ATTRibute-CM Open-Label Extension (OLE) Study

Judge Daniel, Masri Ahmad, Obici Laura, Poulsen Steen, Sarswat Nitasha, Shah Keyur, Soman Prem, Cao Xiaofan, Wang Kevin, Pecoraro Maria, Tamby Jean-francois, Gillmore Julian, Katz Leonid, Fox Jonathan, Maurer Mathew, Alexander Kevin, Ambardekar Amrut, Cappelli Francesco, Fontana Marianna, Garcia-pavia Pablo, Grogan Martha, Hanna Mazen

Impact of vutrisiran on outpatient worsening heart failure in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial

Fontana Marianna, Maurer Mathew, Gillmore Julian, Bender Shaun, Aldinc Emre, Eraly Satish, Jay Patrick, Solomon Scott

More abstracts from these authors:
Building Blocks: How To Build a Clinical Cardio-Oncology Program

Deswal Anita

The Rings of Power: HFrEF Quadruple Therapy and AF

Bozkurt Biykem, Deswal Anita, Dunlay Shannon

You have to be authorized to contact abstract author. Please, Login
Not Available